Management of airway hemangiomas

References

• MacArthur CJ. Head and neck hemangiomas of infancy. Curr. Opin. Otolaryngol. Head Neck Surg.14(6), 397–405 (2006).
   PubMedGoogle Scholar
• Haggstrom AN, Drolet BA, Baselga E et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics118(3), 882–887 (2006).
   PubMed Web of Science ®Google Scholar
• Smith DS, Lee KK, Milczuk HA. Otolaryngologic manifestations of PHACE syndrome. Int. J. Pediatr. Otorhinolaryngol.68(11), 1445–1450 (2004).
   PubMedGoogle Scholar
• O-Lee TJ, Messner A. Subglottic hemangioma. Otolaryngol. Clin. North Am.41(5), 903–911 (2008).
   PubMed Web of Science ®Google Scholar
• Perkins JA, Oliaei S, Garrison MM, Manning SC, Christakis DA. Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals. Int. J. Pediatr. Otorhinolaryngol.73(9), 1302–1307 (2009).
   PubMedGoogle Scholar
• Badi AN, Kerschner JE, North PE, Drolet BA, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int. J. Pediatr. Otorhinolaryngol.73(9), 1187–1191 (2009).
   PubMedGoogle Scholar
• O TM, Alexander RE, Lando T et al. Segmental hemangiomas of the upper airway. Laryngoscope119(11), 2242–2247 (2009).
   PubMedGoogle Scholar
• Perkins JA, Duke W, Chen EY, Manning SC. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol. Head Neck Surg.141(2), 207–212 (2009).
   PubMedGoogle Scholar
• Perkins JA, Chen EY, Hoffer FA, Manning SC. Proposal for staging airway hemangiomas. Otolaryngol. Head Neck Surg.141(4), 516–521 (2009).
   PubMedGoogle Scholar
• Ohlms LA, Jones DT, McGill TJ, Healy GB. Interferon alfa-2a therapy for airway hemangiomas. Ann. Otol. Rhinol. Laryngol.103(1), 1–8 (1994).
   PubMedGoogle Scholar
• MacArthur CJ, Senders CW, Katz J. The use of interferon alfa-2a for life-threatening hemangiomas. Arch. Otolaryngol. Head Neck Surg.121(6), 690–693 (1995).
   PubMedGoogle Scholar
• Soumekh B, Adams GL, Shapiro RS. Treatment of head and neck hemangiomas with recombinant interferon α 2B. Ann. Otol. Rhinol. Laryngol.105(3), 201–206 (1996).
   PubMedGoogle Scholar
• Enjolras O, Breviere G, Roger G et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch. Pediatr.11(2), 99–107 (2004).
   PubMedGoogle Scholar
• Saetti R, Silvestrini M, Cutrone C, Narne S. Treatment of congenital subglottic hemangiomas: our experience compared with reports in the literature. Arch. Otolaryngol. Head Neck Surg.134(8), 848–851 (2008).
   PubMedGoogle Scholar
• Rahbar R, Nicollas R, Roger G et al. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope114(11), 1880–1891 (2004).
   PubMed Web of Science ®Google Scholar
• Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol. Head Neck Surg.132(2), 226–231 (2005).
   PubMedGoogle Scholar
• Pransky SM, Canto C. Management of subglottic hemangioma. Curr. Opin. Otolaryngol. Head Neck Surg.12(6), 509–512 (2004).
   PubMedGoogle Scholar
• Ho K-HK, Ulualp SO. Laser-assisted management of congenital and acquired pediatric airway disorders: case reports and review of the literature. Photomed. Laser Surg.26(6), 601–607 (2008).
   PubMedGoogle Scholar
• Angiero F, Benedicenti S, Benedicenti A, Arcieri K, Berne E. Head and neck hemangiomas in pediatric patients-treated with endolesional 980-nm diode laser. Photomed. Laser Surg.27(4), 553–559 (2009).
   PubMedGoogle Scholar
• Nicolai T, Fischer-Truestedt C, Reiter K, Grantzow R. Subglottic hemangioma: a comparison of CO2 laser, Neodym-Yag laser, and tracheostomy. Pediatr. Pulmonol.39(3), 233–237 (2005).
   PubMedGoogle Scholar
• Naiman AN, Ayari S, Froehlich P. Controlled risk of stenosis after surgical excision of laryngeal hemangioma. Arch. Otolaryngol. Head Neck Surg.129(12), 1291–1295 (2003).
   PubMedGoogle Scholar
• Bajaj Y, Hartley BEJ, Wyatt ME, Albert DM, Bailey CM. Subglottic haemangioma in children: experience with open surgical excision. J. Laryngol. Otol.120(12), 1033–1037 (2006).
   PubMedGoogle Scholar
• Vijayasekaran S, White DR, Hartley BEJ et al. Open excision of subglottic hemangiomas to avoid tracheostomy. Arch. Otolaryngol. Head Neck Surg.132(2), 159–163 (2006).
   PubMedGoogle Scholar
• Leaute-Labreze C, de la Roque ED, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med.358(24), 2649–2651 (2008).
   PubMed Web of Science ®Google Scholar
• Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope120(4), 676–681 (2010).
   PubMed Web of Science ®Google Scholar
• Jephson CG, Manunza F, Syed S et al. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int. J. Pediatr. Otorhinolaryngol.73(12), 1821–1823 (2009).
   PubMed Web of Science ®Google Scholar
• Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int. J. Pediatr. Otorhinolaryngol.74(3), 323–325 (2010).
   PubMedGoogle Scholar
• Denoyelle F, Leboulanger N, Enjolras O et al. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int. J. Pediatr. Otorhinolaryngol.73(8), 1168–1172 (2009).
   PubMedGoogle Scholar
• Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J. Pediatr.156(2), 335–338 (2010).
   PubMedGoogle Scholar
• Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr. Opin. Otolaryngol. Head Neck Surg.17(6), 458–459 (2009).
   PubMedGoogle Scholar
• Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int. J. Pediatr. Otorhinolaryngol.74(4), 338–342 (2010).
   PubMedGoogle Scholar
• Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J. Craniofac. Surg.20(Suppl. 1), 678–684 (2009).
   PubMed Web of Science ®Google Scholar
• Mahajan D, Miller C, Hirose K, McCullough A, Yerian L. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J. Hepatol.49(5), 867–870 (2008).
   PubMed Web of Science ®Google Scholar
• Ach T, Thiemeyer D, Hoeh AE, Schaal KB, Dithmar S. Intravitreal bevacizumab for retinal capillary haemangioma: longterm results. Acta Ophthalmol.88(4), e137–e138 (2010).
   PubMed Web of Science ®Google Scholar
• Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N. Engl. J. Med.362(11), 1005–1013 (2010).
   PubMed Web of Science ®Google Scholar
• Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis12(2), 197–207 (2009).
   PubMed Web of Science ®Google Scholar
• Xiao X, Liu J, Sheng M. Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. J. Pediatr. Surg.39(7), 1107–1110 (2004).
   PubMedGoogle Scholar
• Khan ZA, Boscolo E, Picard A et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J. Clin. Invest.118(7), 2592–2599 (2008).
   PubMed Web of Science ®Google Scholar
• Inglis AF Jr, Perkins JA, Manning SC, Mouzakes J. Endoscopic posterior cricoid split and rib grafting in 10 children. Laryngoscope113(11), 2004–2009 (2003).
   PubMed Web of Science ®Google Scholar